Keywords: بقاء بدون بیماری; Colorectal cancer; Liver metastases; Hepatic resection; Tumor doubling time; Survival; Disease-free survival;
مقالات ISI بقاء بدون بیماری (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بقاء بدون بیماری; Breast cancer; Lymphocyte-to-monocyte ratio; Disease-free survival; Overall survival; Meta-analysis;
Keywords: بقاء بدون بیماری; Breast neoplasms; Radiation therapy; Chemotherapy; Time-to-treatment; Disease-free survival; Overall survival;
Keywords: بقاء بدون بیماری; Breast cancer; ultrasound; shear wave; recurrence; disease-free survival;
Keywords: بقاء بدون بیماری; CRC; colorectal cancer; TNM; tumor-node-metastasis; APC; adenomatous polyposis coli; BER; base excision repair; dRP; deoxyrbose phosphate; AP site; apurinic/abasic site; SN-BER; single-nucleotide base excision repair; LP-BER; long-patch base excision repa
Keywords: بقاء بدون بیماری; CECMP; cytoskeletal and extra-cellular matrix protein; DFS; disease-free survival; ECM; extra-cellular matrix; GDC; genome data commons; OS; overall survival; SNP; single nucleotide polymorphism; SNV; single nucleotide variation; SPSS; statistical package
Keywords: بقاء بدون بیماری; aHR; adjusted HR; BRCA2; breast cancer 2, early onset; CIs; confidence intervals; DFS; disease-free survival; ENCODE; encyclopedia of DNA Elements; ERCC1; excision repair cross-complementing group 1; ERG; V-ets avian erythroblastosis virus E26 oncogene re
Keywords: بقاء بدون بیماری; Muscle wasting; Sarcopenia; NACRT; Rectal carcinoma; Disease-free survival; Overall survival;
Keywords: بقاء بدون بیماری; PBT; proton beam therapy; ESFT; Ewing sarcoma family of tumors; VDC-IE; vincristine, doxorubicin, cyclophosphamide, ifosfamide and etoposide; UTH; University of Tsukuba Hospital; EFS; event-free survival; OS; overall survival; DFS; disease-free survival;
Keywords: بقاء بدون بیماری; Randomized controlled trials; Drug approval; Reproducibility of results; Statistical data interpretation; Disease-free survival; Bias;
Keywords: بقاء بدون بیماری; oral squamous cell carcinoma; mandibulectomy; systematic review; local control; disease-free survival; overall survival; meta-analysis;
Keywords: بقاء بدون بیماری; Krüppel-like factor 4; Meta-analysis; Prognosis; Cancer; Tumor; Carcinoma; TNBC; triple-negative breast cancer; BC; breast cancer; CRC; colorectal cancer; ESCC; esophageal squamous cell carcinoma; GC; gastric cancer; HCC; hepatocellular carcinoma; NPC; n
Keywords: بقاء بدون بیماری; ASA; American Society of Anesthesiologists; CRT; chemoradiotherapy; DSF; disease-free survival; ER; endoscopic resection; M-NBI; magnifying endoscopy with narrow-band imaging; OS; overall survival; PPV; positive predictive value;
Keywords: بقاء بدون بیماری; beta-blockers; cancer recurrence; disease-free survival; overall survival; perioperative;
Keywords: بقاء بدون بیماری; Cabozantinib; Disease-free survival; Network meta-analysis; Nivolumab; Renal cell carcinoma;
Keywords: بقاء بدون بیماری; AML; acute myeloid leukemia; DFS; disease-free survival; DLBCL; diffuse large B-cell lymphoma; DSPC; 1,2-distearoyl-sn-glycero-3-phosphocholine; DSPE; 1,2-distearoyl-sn-glycero-3-phosphoethanolamine; EPR; enhanced permeation and retention; MB; molecular b
Keywords: بقاء بدون بیماری; urinary bladder neoplasms; cystectomy; mortality; female; male; CSS; cancer specific survival; DFS; disease-free survival; OS; overall survival; UCB; urothelial bladder cancer;
Keywords: بقاء بدون بیماری; AI; aromatase inhibitor; ASCO; American Society of Clinical Oncology; CDK4/6; cyclin-dependent kinase 4/6; DCIS; ductal carcinoma in situ; DFS; disease-free survival; ER; estrogen receptor; FDA; Food and Drug Administration; HER2; human epidermal growth f
Keywords: بقاء بدون بیماری; Breast cancer; Disease-free survival; Local control; Radiotherapy;
Keywords: بقاء بدون بیماری; Platelet-to-lymphocyte ratio (PLR); Prognosis; Advanced cancer; Meta-analysis; PLR; platelet-to-lymphocyte ratio; OS; overall survival; PFS; progression-free survival; DFS; disease-free survival; CSS; cancer-specific survival; MeSH; Medical Subject Headin
Keywords: بقاء بدون بیماری; prostatic neoplasms; prostate-specific antigen; brachytherapy; androgen antagonists; disease-free survival; ADT; androgen deprivation therapy; bDFS; biochemical disease-free survival; BF; biochemical failure; EBRT; external beam radiotherapy; LDR-BT; low
Keywords: بقاء بدون بیماری; Pancreatic neuroendocrine neoplasms; Lymph node metastases; Surgery; Pancreaticoduodenectomy; Prognosis; Disease-free survival; PanNENs; Pancreatic Neuroendocrine Neoplasms; PD; pancreaticoduodenectomy; PLN; positive lymph nodes; ELN; examined lymph nodes
Keywords: بقاء بدون بیماری; iFISH; Aneuploid CTC and circulating tumor stem cell; Hepatobiliary malignancy; Hepatocellular and cholangiocarcinoma; Surgical resection; HCC; hepatocellular carcinoma; CC; cholangiocarcinoma; CTC; circulating tumor cell; CTSC; circulating tumor stem cel
Keywords: بقاء بدون بیماری; AML; acute myeloid leukemia; BSC; best supportive care; CI; confidence interval; CIR; cumulative incidence of relapse; CR; complete remission; CRc; composite CR (includes CR, CRi, and CRp); CRi; CR with incomplete hematologic recovery; CRMRDâ; CR with a
Keywords: بقاء بدون بیماری; Hepatocellular carcinoma; Overall survival; Disease-free survival; Outcome; Anatomic resection; Parenchyma-sparing; HCC; Hepatocellular carcinoma; AR; Anatomic resection; PSR; Parenchyma-sparing resection; PSA; Propensity score analysis; DFS; Disease-free
Keywords: بقاء بدون بیماری; adjuvants; immunologic; carcinoma; renal cell; kidney neoplasms; ASSURE; Sunitinib Malate or Sorafenib Tosylate in Treating Patients with Kidney Cancer that was Removed by Surgery; CAIX; carbonic anhydrase IX; DFS; disease-free survival; ECOG; Eastern Coo
Keywords: بقاء بدون بیماری; STIP1; Oncogene; Colorectal cancer; Overall survival; Disease-free survival;
Keywords: بقاء بدون بیماری; DFS; disease-free survival; EGFR; epidermal growth factor receptor; Ex19; exon 19 deletion; Ex21; exon 21 L858R; OS; overall survival; RFS; recurrence-free survival; TKI; tyrosine kinase inhibitor; WT; wild-type;
Keywords: بقاء بدون بیماری; microRNA-331; Breast cancer; Breast benign tumors; Ductal adenocarcinoma; Lobular adenocarcinoma; Biomarker; ASCO; American Society of Clinical Oncologists; AUC; Area under the curve; CAP; College of American Pathologists; cDNA; Complementary DNA; DCIS; D
Keywords: بقاء بدون بیماری; Time-to-treatment; Disease-free survival; Overall survival; Lung cancer; Curative intent treatment; ACCP; American College of Chest Physicians; BTS; British Thoracic Society; CAD; coronary artery disease; CI; confidence interval; COPD; chronic obstructive
Keywords: بقاء بدون بیماری; DCIS; ductal carcinoma in situ; DFS; disease-free survival; NAC; nipple-areola complex; NSM; nipple-sparing mastectomy;
Keywords: بقاء بدون بیماری; Breast cancer; Family history of other cancer; Prognosis; Disease-free survival;
Keywords: بقاء بدون بیماری; cfDNA; circulating free DNA; CK; pan-cytokeratin; CT; competed tomography; CTC; circulating tumor cells; DAPI; 4 6-diamidino-2-phenylindole; DFS; disease-free survival; EDTA; ethylenediaminetetraacetic acid; EGFR; epidermal growth factor receptor; EpCAM;
Keywords: بقاء بدون بیماری; Perineural invasion; Gastric cancer; Oncologic outcomes; Overall survival; Disease-free survival;
Keywords: بقاء بدون بیماری; Carcinoma; Squamous cell; Oral cavity; World Health Organization; Neoplasm grading; Disease-free survival;
Keywords: بقاء بدون بیماری; aCGH; array comparative genomic hybridization; CIMP; CpG island methylator phenotype; CIN; chromosomal instability; CNA; copy number alteration; CRC; colorectal cancer; DFS; disease-free survival; EOCRC; early-onset colorectal cancer; GII; genomic Instabi
Keywords: بقاء بدون بیماری; Vascular inflow occlusion; Liver resection; Colorectal liver metastases; Disease-free survival;
Keywords: بقاء بدون بیماری; CC; colon cancer; DFS; disease-free survival; HR; hazard ratio; HRT; hormone replacement therapy; MSI; microsatellite instability; OS; overall survival;
Keywords: بقاء بدون بیماری; CEA; carcinoembryonic antigen; CI; confidence interval; CRC; colorectal cancer; CT; surgical resection followed by adjuvant chemotherapy; DFI; disease-free interval; DFS; disease-free survival; HR; hazard ratio; LN; lymph node; OS; overall survival; PM; p
Keywords: بقاء بدون بیماری; computed tomography-guided 18-gauge core needle biopsy (CTNB); high-grade adenocarcinoma; lung adenocarcinoma; radial probe endobronchial ultrasound (R-EBUS); subtype; CI; confidence interval; CT; computed tomography; CTNB; computed tomography-guided 18
Keywords: بقاء بدون بیماری; DFS; disease-free survival; HR; hazard ratio; MSS; melanoma-specific survival; OS; overall survival; PAM; pregnancy-associated melanoma;
Keywords: بقاء بدون بیماری; CSC; cancer stem cells; DCLK1; doublecortin-like kinase 1; DMSO; dimethyl sulfoxide; DFS; disease-free survival; HNSCC; head and neck squamous cell carcinoma; HPSCC; hypopharyngeal squamous cell carcinoma; HPV; human papilloma virus; LRRK-2-in-1; leucine
Keywords: بقاء بدون بیماری; Oestrogen receptor beta; Colorectal cancer; Cancer prognosis; Overall survival; Disease-free survival;
Keywords: بقاء بدون بیماری; Breast neoplasms; Antineoplastic agents; Hormonal biological products; Biological markers; Disease-free survival;
Keywords: بقاء بدون بیماری; ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: بقاء بدون بیماری; AC; adenocarcinoma; ARCON; accelerated radiotherapy with carbogen breathing and nicotinamide; CA IX; carbonic anhydrase; CCRT; concurrent chemoradiotherapy; CR; complete response; Cu-ATSM,; copper-62 labeled diacetyl-bis (N4-methylthiosemicarbazone); DFS;
Keywords: بقاء بدون بیماری; AL; acute leukemia; ALL; acute lymphoblastic leukemia; ALT; alanine aminotranferase; AML; acute myeloid leukemia; AST; aspartate aminotransferase; CHF; congestive heart failure; CRP; C-reactive protein; DFO; deferoxamine; DFS; disease-free survival; DFX;
Keywords: بقاء بدون بیماری; kidney neoplasms; carcinoma; renal cell; nephrectomy; neoplasm recurrence; local; mortality; BMI; body mass index; CCI; Charlson comorbidity index; CT; computerized tomography; DFS; disease-free survival; EPV; events per variable; LVI; lymphovascular inva
Keywords: بقاء بدون بیماری; Tumor-infiltrating lymphocytes; TIL; Breast carcinoma; Adjuvant therapy; Non-neoadjuvant therapy; Overall survival; Disease-free survival;
Keywords: بقاء بدون بیماری; Disease-free survival; Mortality; Prostate cancer; Prostate-specific antigen; Prostatectomy;